
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook
WILMINGTON, DE — Enovis Corporation (NYSE: ENOV) reported solid second-quarter results, posting 7% year-over-year sales growth and raising its full-year financial guidance amid continued momentum in its orthopedic business segments.
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook Read More